tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Income Statement

211 Followers

Phathom Pharmaceuticals Income Statement

Last quarter (Q4 2023), Phathom Pharmaceuticals's total revenue was $682.00K, an increase of Infinity% from the same quarter last year. In Q4, Phathom Pharmaceuticals's net income was $-79.57M. See Phathom Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 682.00K$ 682.00K--$ 0.00$ 0.00
Cost of Revenue
$ 167.00K$ 167.00K----
Gross Profit
$ 515.00K$ 515.00K----
Operating Expense
$ 167.83M$ 167.83M$ 172.44M$ 135.08M$ 125.67M$ 27.32M
Operating Income
$ -167.31M$ -167.31M$ -172.44M$ -135.08M$ -125.67M$ -27.32M
Net Non Operating Interest Income Expense
$ -34.09M$ -34.09M$ -25.17M$ -6.75M$ -3.49M$ -3.09M
Other Income Expense
$ 188.00K$ 188.00K$ 110.00K$ 2.06M$ 87.00K$ -224.72M
Pretax Income
$ -201.43M$ -201.43M$ -197.72M$ -143.88M$ -129.07M$ -255.13M
Tax Provision
$ -4.31M$ -4.31M----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -201.59M$ -201.59M$ -197.72M$ -143.88M$ -129.07M$ -255.13M
Basic EPS
$ -3.87$ -3.93$ -5.05$ -3.89$ -3.88$ -22.45
Diluted EPS
$ -3.87$ -3.93$ -5.05$ -3.89$ -3.88$ -22.45
Basic Average Shares
$ 205.16M$ 51.29M$ 39.12M$ 37.00M$ 33.23M$ 11.37M
Diluted Average Shares
$ 205.16M$ 51.29M$ 39.12M$ 37.00M$ 33.23M$ 11.37M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 167.99M$ 167.99M$ 172.44M$ 135.08M$ 125.67M$ 27.32M
Net Income From Continuing And Discontinued Operation
$ -201.59M$ -201.59M$ -197.72M$ -143.88M$ -129.07M$ -255.13M
Normalized Income
$ -150.24M$ -205.74M$ -156.20M-$ -129.16M$ -79.96M
Interest Expense
----$ 4.58M$ 4.18M
EBIT
$ -159.46M$ -159.46M$ -170.42M$ -137.09M$ -124.49M$ -250.95M
EBITDA
$ -157.00M$ -157.00M$ -167.69M$ -132.98M$ -124.16M$ -250.95M
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis